Use of a suspension of gas-filled microbubbles comprising a fatty acids di-ester of phosphatidylcholine (PC), a pegylated phos-phatidylethanolamines (PE-PEG) and a fatty acid in a therapeutic method, wherein said suspension is administered as subsequent boluses.

Use of a suspension of gas-filled microbubbles comprising a fatty acids di-ester of phosphatidylcholine (PC), a pegylated phos-phatidylethanolamines (PE-PEG) and a fatty acid in a therapeutic method, wherein said suspension is administered as subsequent boluses.

This invention relates to oral care compositions comprising herbal extracts including, e.g., Gymnema sylvestre, Emblica officinalis, Eugenia jambolana, Azadirachta indica, and combinations thereof and zinc salts, e.g., zinc citrate and zinc oxide. Additionally, the invention relates to methods of using and of making these compositions, e.g., method of using the oral care compositions to treat gingivitis in diabetic consumers.

This invention relates to oral care compositions comprising herbal extracts including, e.g., Gymnema sylvestre, Emblica officinalis, Eugenia jambolana, Azadirachta indica, and combinations thereof and zinc salts, e.g., zinc citrate and zinc oxide. Additionally, the invention relates to methods of using and of making these compositions, e.g., method of using the oral care compositions to treat gingivitis in diabetic consumers.

The invention provides novel compositions comprising semifluorinated alkanes and at least one compound sensitive or prone to oxidation. The compositions can be used as medicines that are topically administered to an eye or ophthalmic tissue. The invention further provides kits comprising such compositions.

In various embodiments a dental varnish system having improved peptide release and fluoride release properties is provided. In various embodiments a dental varnish system that provides release of an antimicrobial peptide, or specifically targeted antimicrobial peptide (STAMP), e.g., the peptide C16G2, is provided, with or without a fluoride. In various embodiments, a dental varnish system that provides release of a fluoride, with or without an antimicrobial peptide or STAMP is provided. In certain embodiments the dental varnish system comprises a first component that is a dry powder, said first component comprising a an antimicrobial peptide, with or without a fluoride, and a bulking agent, and a second component that is a fluid, said second component comprising a varnish solution, where combination of said first component with said second component provides a varnish formulation for application to the surface of a tooth.

Articles, compositions, and methods for treating textiles and other materials with an antimicrobial compound during laundry and/or drying cycles are described. The articles and compositions include a metal ion having antimicrobial efficacy. Methods include the use of the articles and compositions in laundry and/or drying cycles to provide antimicrobial treatment of the textiles and materials.

Articles, compositions, and methods for treating textiles and other materials with an antimicrobial compound during laundry and/or drying cycles are described. The articles and compositions include a metal ion having antimicrobial efficacy. Methods include the use of the articles and compositions in laundry and/or drying cycles to provide antimicrobial treatment of the textiles and materials.

The present invention relates to the use of halogen compounds, including iodide, and chalcogenide compounds, including iodide, sulfide and selenide, to treat and prevent diseases and injuries. The present invention further relates to compositions comprising a halogen compound and/or a chalcogenide compound, including pharmaceutical compositions, as well as methods of manufacturing such compounds and administering such compositions to subjects in need thereof.

The present invention relates to the use of halogen compounds, including iodide, and chalcogenide compounds, including iodide, sulfide and selenide, to treat and prevent diseases and injuries. The present invention further relates to compositions comprising a halogen compound and/or a chalcogenide compound, including pharmaceutical compositions, as well as methods of manufacturing such compounds and administering such compositions to subjects in need thereof.